R. Tripathy

发表

TrkA kinase inhibitors from a library of modified and isosteric Staurosporine aglycone.

J. Mallamo, T. Angeles, R. Tripathy, 2008, Bioorganic & medicinal chemistry letters.

Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis.

E. Bacon, B. Ruggeri, J. Mallamo, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain I.

D. Bozyczko‐Coyne, J. Mallamo, G. Wells, 1997, Journal of medicinal chemistry.

Diels-Alder reaction of dienes having stereogenic allylic substituents: control of diastereoface selectivity by the dienophile

R. Franck, R. Tripathy, K. Onan, 1988 .

1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors.

A. Ghose, E. Bacon, J. Mallamo, 2007, Bioorganic & medicinal chemistry letters.

Pyrazolone-based anaplastic lymphoma kinase (ALK) inhibitors: control of selectivity by a benzyloxy group.

A. Ghose, B. Dorsey, T. Angeles, 2011, Bioorganic & medicinal chemistry letters.

Asymmetric Diels-Alder reactions with chiral dienes. Control of facial selectivity through hydrogen bonding

P. Carroll, E. Thornton, R. Tripathy, 1990 .

Diels‐Alder Reaction of Dienes Having Stereogenic Allylic Substituents: Control of Diastereoface Selectivity by the Dienophile.

R. Franck, R. Tripathy, K. Onan, 1988 .

Diene-dienophile hydrogen-bonding control of Diels-Alder reactions with dienes bearing a remote stereogenic center. Amplification of the receptor nature of dienes by conformational tuning leading to high diastereofacial discrimination

P. Carroll, E. Thornton, R. Tripathy, 1991 .

Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity.

Andrew V. Anzalone, B. Ruggeri, T. Underiner, 2010, ACS medicinal chemistry letters.

Subsite requirements for peptide aldehyde inhibitors of human calpain I

Eric C. Griffith, D. Bozyczko‐Coyne, M. Ator, 1997 .

Effect of allylic substituents on the face selectivity of Diels-Alder reactions of semicyclic dienes

G. Quigley, S. Datta, R. Franck, 1990 .

Strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: identification of orally bioavailable, efficacious ALK inhibitors.

K. Wells-Knecht, H. Breslin, B. Dorsey, 2012, Journal of medicinal chemistry.

D-amino acid containing, high-affinity inhibitors of recombinant human calpain I.

D. Bozyczko‐Coyne, J. Mallamo, S. Chatterjee, 1998, Journal of medicinal chemistry.

P2-proline-derived inhibitors of calpain I.

M. Ator, D. Dunn, S. Chatterjee, 1998, Bioorganic & medicinal chemistry letters.

Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT₆ receptor antagonist showing activity in rat social recognition test.

Karla K Kopec, E. Duzic, E. Bacon, 2012, Bioorganic & medicinal chemistry letters.

Discovery of 7‐Arylsulfonyl‐1,2,3,4,4a,9a‐hexahydro‐benzo[4,5]furo[2,3‐c]pyridines: Identification of a Potent and Selective 5‐HT6 Receptor Antagonist (I) Showing Activity in Rat Social Recognition Test.

R. Tripathy, 2012 .

Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitors.

K. L. Milkiewicz, T. Underiner, B. Dorsey, 2011, Bioorganic & medicinal chemistry letters.

Construction of a kinase inhibitor library via parallel synthesis

J. Mallamo, Jasbir Singh, R. Tripathy, 2002 .